Plexus (PLXS) Set to Announce Quarterly Earnings on Wednesday

by · The Cerbat Gem

Plexus (NASDAQ:PLXS – Get Free Report) is set to issue its quarterly earnings data after the market closes on Wednesday, October 23rd. Analysts expect the company to announce earnings of $1.53 per share for the quarter. Plexus has set its Q4 guidance at $1.50-1.65 EPS and its Q4 2024 guidance at 1.500-1.650 EPS.Parties interested in participating in the company’s conference call can do so using this link.

Plexus (NASDAQ:PLXS – Get Free Report) last announced its quarterly earnings results on Wednesday, July 24th. The technology company reported $1.45 earnings per share for the quarter, topping the consensus estimate of $1.28 by $0.17. Plexus had a net margin of 2.82% and a return on equity of 9.64%. The firm had revenue of $960.70 million during the quarter, compared to analysts’ expectations of $981.32 million. During the same quarter in the prior year, the company earned $1.32 EPS. The company’s revenue was down 6.0% compared to the same quarter last year. On average, analysts expect Plexus to post $4 EPS for the current fiscal year and $6 EPS for the next fiscal year.

Plexus Price Performance

Shares of PLXS opened at $136.23 on Tuesday. The company has a 50 day moving average price of $129.43 and a 200-day moving average price of $115.21. Plexus has a fifty-two week low of $87.21 and a fifty-two week high of $139.98. The stock has a market capitalization of $3.73 billion, a PE ratio of 37.63 and a beta of 0.89. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.64 and a current ratio of 1.47.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on the stock. Needham & Company LLC increased their target price on shares of Plexus from $114.00 to $144.00 and gave the company a “buy” rating in a research report on Friday, July 26th. Benchmark reissued a “buy” rating and set a $150.00 target price on shares of Plexus in a research report on Monday. Two analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $125.25.

View Our Latest Research Report on Plexus

Insider Activity at Plexus

In related news, Director Karen Marie Rapp sold 500 shares of the stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $128.02, for a total transaction of $64,010.00. Following the completion of the sale, the director now owns 9,586 shares of the company’s stock, valued at $1,227,199.72. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. In other Plexus news, CEO Todd P. Kelsey sold 3,000 shares of the firm’s stock in a transaction on Wednesday, July 31st. The shares were sold at an average price of $128.40, for a total value of $385,200.00. Following the completion of the transaction, the chief executive officer now owns 93,682 shares of the company’s stock, valued at approximately $12,028,768.80. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Karen Marie Rapp sold 500 shares of the firm’s stock in a transaction on Friday, August 30th. The stock was sold at an average price of $128.02, for a total transaction of $64,010.00. Following the completion of the transaction, the director now directly owns 9,586 shares of the company’s stock, valued at approximately $1,227,199.72. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 20,113 shares of company stock valued at $2,541,394 over the last 90 days. Insiders own 2.39% of the company’s stock.

Plexus Company Profile

(Get Free Report)

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.

See Also